← Leaderboards
Alistair McGregor
University Of Minnesota
$8,487,942
Attributed
$8,487,942
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $951.9K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,487,942 · 6
By mechanism
R01$7,685,406 · 4
R21$802,536 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Mark R. Schleiss$10,248,102
- James R Lokensgard$16,261,665
- Yuying Liang$5,110,790
- Joseph Mark Metzger$31,677,280
- Craig John Bierle$2,400,280
Others in their field
Top investigators on “Virus Diseases”
- Barton F Haynes · Duke University$305,832,186
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Lawrence Corey · Fred Hutchinson Cancer Center$271,990,515
- Richard Webby · St. Jude Children'S Research Hospital$264,105,723
- David Heimbrook · Leidos Biomedical Research, Inc.$262,417,885
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$252,117,999
Research focus
Virus DiseasesCongenital CytomegalovirusVaccinesVirusCytomegalovirus VaccinesGuinea Pig CytomegalovirusImmunocompromised HostNewborn InfantImmune ResponseMorbidity - Disease RateMental RetardationCaviaCytomegalovirusPathogenAcquired Immunodeficiency SyndromeGlycoproteinsFetusIn UteroAnimal ModelCellsProteinsEpithelial CellsTransplantationFibroblasts
Grant awards (24)
Development of a universal DISC vaccine strategy against congenital cytomegalovirus$655,677
R01 · FY2025 · AI · contact PI
Development of a universal DISC vaccine strategy against congenital cytomegalovirus$655,677
R01 · FY2024 · AI · contact PI
Development of a universal DISC vaccine strategy against congenital cytomegalovirus$668,331
R01 · FY2023 · AI · contact PI
Development of a universal DISC vaccine strategy against congenital cytomegalovirus$668,331
R01 · FY2022 · AI · contact PI
Development of a universal DISC vaccine strategy against congenital cytomegalovirus$649,911
R01 · FY2021 · AI · contact PI
CMV pentameric complex based vaccine strategies for prevention of congenital CMV$301,975
R01 · FY2021 · HD · contact PI
CMV pentameric complex based vaccine strategies for prevention of congenital CMV$308,138
R01 · FY2020 · HD · contact PI
CMV pentameric complex based vaccine strategies for prevention of congenital CMV$308,138
R01 · FY2019 · HD · contact PI
CMV pentameric complex based vaccine strategies for prevention of congenital CMV$308,138
R01 · FY2018 · HD · contact PI
CMV pentameric complex based vaccine strategies for prevention of congenital CMV$303,307
R01 · FY2017 · HD · contact PI
Placental trophoblast infection and TLR mediated response to congenital CMV$371,200
R01 · FY2015 · AI · contact PI
Development of an effective DISC vaccine strategy against congenital CMV$363,750
R01 · FY2015 · AI · contact PI
Placental trophoblast infection and TLR mediated response to congenital CMV$371,200
R01 · FY2014 · AI · contact PI
Development of an effective DISC vaccine strategy against congenital CMV$363,750
R01 · FY2014 · AI · contact PI
Placental trophoblast infection and TLR mediated response to congenital CMV$349,128
R01 · FY2013 · AI · contact PI
Development of an effective DISC vaccine strategy against congenital CMV$342,121
R01 · FY2013 · AI · contact PI
Vaccine against CMV endothelial tropism & congenital infection$205,566
R21 · FY2013 · AI · contact PI
Placental trophoblast infection and TLR mediated response to congenital CMV$197,025
R01 · FY2012 · AI · contact PI
Development of an effective DISC vaccine strategy against congenital CMV$188,828
R01 · FY2012 · AI · contact PI
Vaccine against CMV endothelial tropism & congenital infection$183,760
R21 · FY2012 · AI · contact PI
Placental trophoblast infection and TLR mediated response to congenital CMV$168,415
R01 · FY2012 · AI · contact PI
Development of an effective DISC vaccine strategy against congenital CMV$142,366
R01 · FY2012 · AI · contact PI
Novel vaccine to CMV based on a disc virus$226,500
R21 · FY2010 · AI · contact PI
Novel vaccine to CMV based on a disc virus$186,710
R21 · FY2009 · AI · contact PI